Circulating form of human vascular adhesion protein-1 (VAP-1): Decreased serum levels in progression of colorectal cancer and predictive marker of lymphatic and hepatic metastasis

Journal of Surgical Oncology

Volumn 99, Issue 6, 2009, Pages 368-372

  Toiyama, Yuji ^a   Miki, Chikao ^a   Inoue, Yasuhiro ^a   Kawamoto, Aya ^a   Kusunoki, Masato ^a  

^a MIE UNIVERSITY   (Japan)

Author keywords

Colorectal cancer; Hepatic metastasis; Lymph node metastasis; Prognostic factor; sVAP 1

Indexed keywords

VASCULAR ADHESION PROTEIN 1; AMINE OXIDASE (COPPER CONTAINING); AOC3 PROTEIN, HUMAN; CELL ADHESION MOLECULE; TUMOR MARKER;

ADVANCED CANCER; AGED; ARTICLE; CANCER CLASSIFICATION; CANCER GROWTH; CLINICAL FEATURE; COLORECTAL CANCER; CONTROLLED STUDY; DISTANT METASTASIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; LIVER METASTASIS; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; BLOOD; CANCER INVASION; CANCER STAGING; COLORECTAL TUMOR; DISEASE COURSE; KAPLAN MEIER METHOD; LIVER TUMOR; LYMPH NODE; METASTASIS; MIDDLE AGED; MORTALITY; MULTIVARIATE ANALYSIS; PATHOLOGY; PREDICTION AND FORECASTING; STATISTICAL MODEL;

AGED; AMINE OXIDASE (COPPER-CONTAINING); CELL ADHESION MOLECULES; COLORECTAL NEOPLASMS; DISEASE PROGRESSION; FEMALE; HUMANS; KAPLAN-MEIERS ESTIMATE; LIVER NEOPLASMS; LOGISTIC MODELS; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 65449134008     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.21246     Document Type: Article

References (38)

1. Jass JR, Love SB, Northover JM: A new prognostic classification of rectal cancer. Lancet 1987;1:1303-1306. (Pubitemid 17072200)
2. Ropponen KM, Eskelinen MJ, Lipponen PK, et al.: Prognostic value of tumour-infiltrating lymphocytes (TILs) in colorectal cancer. J Pathol 1997;182:318-324.
3. Butcher EC: Leukocyte-endothelial cell recognition: Three (or more) steps to specificity and diversity. Cell 1991;67:1033-1036. (Pubitemid 121001517)
4. Springer TA: Traffic signals for lymphocyte recirculation and leukocyte emigration: The multistep paradigm. Cell 1994;76:301-314. (Pubitemid 24046692)
5. Carlos TM, Harlan JM: Leukocyte-endothelial adhesion molecules. Blood 1994;84:2068-2101. (Pubitemid 24296363)
6. Salmi M, Jalkanen S: A 90-kilodalton endothelial cell molecule mediating lymphocyte binding in humans. Science 1992;257:1407-1409.
7. Salmi M, Tohka S, Berg EL, et al.: Vascular adhesion protein 1 (VAP-1) mediates lymphocyte subtype-specific, selectin-independent recognition of vascular endothelium in human lymph nodes. J Exp Med 1997;186:589-600.
8. Yoong KF, McNab G, Hübscher SG, et al.: Vascular adhesion protein-1 and ICAM-1 support the adhesion of tumor-infiltrating lymphocytes to tumor endothelium in human hepatocellular carcinoma. J Immunol 1998;160:3978-3988.
9. Kurkijärvi R, Adams DH, Leino R, et al.: Circulating form of human vascular adhesion protein-1 (VAP-1): Increased serum levels in inflammatory liver diseases. J Immunol 1998;161:1549-1557.
10. Madej A, Reich A, Orda A, et al.: Expression of vascular adhesion protein-1 in atopic eczema. Int Arch Allergy Immunol 2006;139:114-121.
11. Seth R, Raymond FD, Makgoba MW: Circulating ICAM-1 isoforms: Diagnostic prospects for inflammatory and immune disorders. Lancet 1991;338:83-84.
12. Rothlein R, Mainolfi EA, Czajkowski M, et al.: A form of circulating ICAM-1 in human serum. J Immunol 1991;147:3788-3793.
13. Gearing AJ, Hemingway I, Pigott R, et al.: Soluble forms of vascular adhesion molecules, E-selectin, ICAM-1, and VCAM-1: Pathological significance. Ann NY Acad Sci 1992;667:324-331. (Pubitemid 23061599)
14. Wellicome SM, Kapahi P, Mason JC, et al.: Detection of a circulating form of vascular cell adhesion molecule-1: Raised levels in rheumatoid arthritis and systemic lupus erythematosus. Clin Exp Immunol 1993;92:412-418.
15. Goldberger A, Middleton KA, Oliver JA, et al.: Biosynthesis and processing of the cell adhesion molecule PECAM-1 includes production of a soluble form. J Biol Chem 1994;269:17183-17191.
16. Newman W, Beall LD, Carson CW, et al.: Soluble E-selectin is found in supernatants of activated endothelial cells and is elevated in the serum of patients with septic shock. J Immunol 1993;150:644-654.
17. Schleiffenbaum B, Spertini O, Tedder TF: Soluble L-selectin is present in human plasma at high levels and retains functional activity. J Cell Biol 1992;119:229-238.
18. Dunlop LC, Skinner MP, Bendall LJ, et al.: Characterization of GMP-140 (P-selectin) as a circulating plasma protein. J Exp Med 1992;175:1147-1150.
19. Lucas MG, Green AM, Telen MJ: Characterization of the serum In(Lu)-related antigen: Identification of a serum protein related to erythrocyte p80. Blood 1989;73:596-600. (Pubitemid 19060549)
20. Bazil V: Physiological enzymatic cleavage of leukocyte membrane molecules. Immunol Today 1995;16:135-140.
21. Johnston GI, Cook RG, McEver RP: Cloning of GMP-140, a granule membrane protein of platelets and endothelium: Sequence similarity to proteins involved in cell adhesion and inflammation. Cell 1989;56:1033-1044. (Pubitemid 19091015)
22. Johnston GI, Bliss GA, Newman PJ, et al.: Structure of the human gene encoding granule membrane protein-140, a member of the selectin family of adhesion receptors for leukocytes. J Biol Chem 1990;265:21381-21385.
23. Meyer DM, Dustin ML, Carron CP: Characterization of intercellular adhesion molecule-1 ectodomain (sICAM-1) as an inhibitor of lymphocyte function-associated molecule-1 interaction with ICAM-1. J Immunol 1995;155:3578-3584.
24. Sanchez-Rovira P, Jimenez E, Carracedo J, et al.: Serum levels of intercellular adhesion molecule 1 (ICAM-1) in patients with colorectal cancer: Inhibitory effect on cytotoxicity. Eur J Cancer 1998;34:394-398.
25. Velikova G, Banks RE, Gearing A, et al.: Serum concentrations of soluble adhesion molecules in patients with colorectal cancer. Br J Cancer 1998;77:1857-1863.
26. Wittig BM, Kaulen H, Thees R, et al.: Elevated serum E-selectin in patients with liver metastases of colorectal cancer. Eur J Cancer 1996;32:1215-1218.
27. Franzke A, Probst-Kepper M, Buer J, et al.: Elevated pretreatment serum levels of solublevascular cell adhesion molecule 1 and lactate dehydrogenase as predictors of survival in cutaneous metastatic malignant melanoma. Br J Cancer 1998;78:40-45.
28. Zhang GJ, Adachi I: Serum levels of soluble intercellular adhesion molecule-1 and E-selectin in metastatic breast carcinoma: Correlations with clinicopathological features and prognosis. Int J Oncol 1999;14:71-77.
29. Hebbar M, Révillion F, Louchez MM, et al.: The relationship between concentrations of circulating soluble E-selectin and clinical, pathological, and biological features in patients with breast cancer. Clin Cancer Res 1998;4:373-380.
30. Nakata B, Hori T, Sunami T, et al.: Clinical significance of serum soluble intercellular adhesion molecule 1 in gastric cancer. Clin Cancer Res 2000;6:1175-1179.
31. Alexiou D, Karayiannakis AJ, Syrigos KN, et al.: Serum levels of E-selectin, ICAM-1 and VCAM-1 in colorectal cancer patients: Correlations with clinicopathological features, patient survival and tumour surgery. Eur J Cancer 2001;37:2392-2397. (Pubitemid 33097476)
32. Alexiou D, Karayiannakis AJ, Syrigos KN, et al.: Clinical significance of serum levels of E-selectin, intercellular adhesion molecule-1, and vascular cell adhesion molecule-1 in gastric cancer patients. Am J Gastroenterol 2003;98:478-485.
33. Salmi M, Jalkanen S: Humanvascular adhesion protein-1 (vap-1) is a unique sialoglycoprotein that mediates carbohydrate-dependent binding of lymphocytes to endothelial-cells. J Exp Med 1996;183:569-579. (Pubitemid 26060791)
34. Salmi M, Kalimo K, Jalkanen S: Induction and function of vascular adhesion protein-1 at sites of inflammation. J Exp Med 1993;178:2255-2260. (Pubitemid 23344887)
35. Kurkijärvi R, Yegutkin GG, Gunson BK, et al.: Circulating soluble vascular adhesion protein 1 accounts for the increased serum monoamine oxidase activity in chronic liver disease. Gastroenterology 2000;119:1096-1103.
36. Airas L, Mikkola J, Vainio JM, et al.: Elevated serum soluble vascular adhesion protein-1 (VAP-1) in patients with active relapsing remitting multiple sclerosis. J Neuroimmunol 2006;177:132-135.
37. Koch M, Beckhove P, Op den Winkel J, et al.: Tumor infiltrating T lymphocytes in colorectal cancer: Tumor-selective activation and cytotoxic activity in situ. Ann Surg 2006;244:986-992.
38. Schumacher P, Dineen S, Barnett C, Jr., et al.: The metastatic lymph node ratio predicts survival in colon cancer. Am J Surg 2007;194:827-831.